{"mainPropery":{"diseaseId":2429,"diseaseName":"Limb-girdle muscular dystrophy, type 2C","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2429/limb-girdle-muscular-dystrophy-type-2c","synonyms":["Limb-girdle muscular dystrophy with gamma-sarcoglycan deficiency","Gamma-sarcoglycanopathy","LGMD2C","Muscular dystrophy, Duchenne-like","Duchenne-like muscular dystrophy, autosomal recessive, type 1","DMDA1","Adhalin deficiency, secondary","DMDA","Severe childhood autosomal recessive muscular dystrophy, North African type","Maghrebian myopathy","Autosomal recessive limb-girdle muscular dystrophy type 2C","Limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency","Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5","Gamma-sarcoglycan-related LGMD R5","LGMD due to gamma-sarcoglycan deficiency","LGMD type 2C","Limb-girdle muscular dystrophy type 2C"],"synonyms-with-source":[{"name":"Limb-girdle muscular dystrophy with gamma-sarcoglycan deficiency"},{"name":"Gamma-sarcoglycanopathy"},{"name":"LGMD2C"},{"name":"Muscular dystrophy, Duchenne-like"},{"name":"Duchenne-like muscular dystrophy, autosomal recessive, type 1"},{"name":"DMDA1"},{"name":"Adhalin deficiency, secondary"},{"name":"DMDA"},{"name":"Severe childhood autosomal recessive muscular dystrophy, North African type"},{"name":"Maghrebian myopathy"},{"name":"Autosomal recessive limb-girdle muscular dystrophy type 2C","source":"OrphaData.Org"},{"name":"Limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency","source":"OrphaData.Org"},{"name":"Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5","source":"OrphaData.Org"},{"name":"Gamma-sarcoglycan-related LGMD R5","source":"OrphaData.Org"},{"name":"LGMD due to gamma-sarcoglycan deficiency","source":"OrphaData.Org"},{"name":"LGMD type 2C","source":"OrphaData.Org"},{"name":"Limb-girdle muscular dystrophy type 2C","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"253700"},{"identifierType":"ORPHANET","identifierId":"353"},{"identifierType":"UMLS","identifierId":"C0410173"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":87,"resourceName":"Muscular Dystrophy Family Foundation","abbreviation":"","address1":"P.O. Box 776","address2":"","address3":"","address4":"","address5":"","city":"Carmel","state":"IN","zip":"46082","country":"United States","phone":"+1-317-615-9140","tty":"","tollFree":"","fax":"","email":"info@mdff.org","url":"https://mdff.org/","freeText":"MDFF provides financial assistance, quality programs and services for the Muscular Dystrophy community in Indiana."},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/253700' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=253700' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Limb-girdle muscular dystrophy, type 2C. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Limb-girdle+muscular+dystrophy+type+2C%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Limb-girdle muscular dystrophy, type 2C. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/limb-girdle-muscular-dystrophy' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Limb-girdle muscular dystrophy, type 2C. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/904/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000711.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='http://www.ninds.nih.gov/disorders/md/detail_md.htm' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/1170911-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=353' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=lgmd-overview' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_Search_Simple.php?lng=EN&LnkId=8734&Typ=Pat&RchTyp=Rch' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=8734&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:253700' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1832,"questionText":"What is limb-girdle muscular dystrophy type 2C?","answerText":"<strong>Limb-girdle muscular dystrophy type 2C (LGMD2C)</strong>&nbsp;is a genetic condition that affects the voluntary muscles around the hips and shoulders. This condition belongs to a group of muscle disorders called <a href=\"https://rarediseases.info.nih.gov/gard/6907/limb-girdle-muscular-dystrophy/resources/1\" target=\"_blank\">limb-girdle muscular dystrophies</a>,&nbsp;which are characterized by&nbsp;progressive loss of muscle bulk and symmetrical weakening of voluntary muscles. Symptoms of LGMD2C usually appear around 6-8 years of age, may be mild or severe, and can progress to loss of the ability to walk by 12-16 years. Symptoms may additionally include: enlargement (hypertrophy) of the calf muscle and tongue, diseases of the heart muscle (<a href=\"https://medlineplus.gov/cardiomyopathy.html\" target=\"_blank\">cardiomyopathy</a>), and respiratory abnormalities.[10986][11997] LGMD2C is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <a href=\"https://ghr.nlm.nih.gov/gene/SGCG\" target=\"_blank\"><em>SGCG</em></a> gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal&nbsp;recessive</a> manner.[1117]&nbsp;Although there is no specific treatment or cure for LGMD2C, there are ways to manage the symptoms. A team of doctors or specialists is often needed to figure out the treatment options for each person.[10986]<br />\r\n<br />","dateModified":"2016-08-09T00:00:00"},"basicQuestions":[{"questionId":1833,"questionText":"How might limb-girdle muscular dystrophy, type 2C (LGMD2C) be treated?&nbsp;","answerText":"There is no specific treatment for LGMD2C. Management of the condition is based on each person's symptoms and may include:[1118]\r\n<ul>\r\n    <li>Weight control to avoid obesity\r\n    </li>\r\n    <li>Physical therapy and stretching exercises to promote mobility and prevent contractures\r\n    </li>\r\n    <li>Use of mechanical aids such as canes, walkers, orthotics, and wheelchairs as needed to help ambulation and mobility\r\n    </li>\r\n    <li>Monitoring and surgical intervention as needed for orthopedic complications such as foot deformity and <a href=\"http://www.niams.nih.gov/Health_Info/Scoliosis/scoliosis_ff.asp\" target=\"_blank\">scoliosis</a>\r\n    </li>\r\n    <li>Monitoring of respiratory function and use of respiratory aids when indicated\r\n    </li>\r\n    <li>Monitoring for evidence of diseases of the heart muscle (<a href=\"http://www.nlm.nih.gov/medlineplus/cardiomyopathy.html\" target=\"_blank\">cardiomyopathy</a>)</li>\r\n    <li>Social and emotional support and stimulation to maximize a sense of social involvement and productivity and to reduce the sense of social isolation common in these disorders</li>\r\n</ul>","dateModified":"2016-08-09T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1118,"authors":"Pegoraro E and Hoffman EP","articleTitle":"Limb-Girdle Muscular Dystrophy Overview","bookWebsiteJournalTitle":"GeneReviews","date":"August 30, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1408/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":6907,"relatedDiseaseName":"Limb-girdle muscular dystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":23559,"abbreviatedInquiry":"I live in Serbia, and I'm looking all around the world to find somebody who may give me&nbsp;hope and help me with my problem. In 1998 when I was 12-years-old, I suddenly felt some pains in my leg muscles and from that moment I have problems with my all body muscles. Now I am 23 and I still walk on my own but it is very hard. Two years ago&nbsp;I was diagnosed with gamma-sarcoglycanopathy (LGMD2C).&nbsp;","caseQuestions":[{"questionId":1832,"questionText":"What is limb-girdle muscular dystrophy type 2C?","answerText":"<strong>Limb-girdle muscular dystrophy type 2C (LGMD2C)</strong>&nbsp;is a genetic condition that affects the voluntary muscles around the hips and shoulders. This condition belongs to a group of muscle disorders called <a href=\"https://rarediseases.info.nih.gov/gard/6907/limb-girdle-muscular-dystrophy/resources/1\" target=\"_blank\">limb-girdle muscular dystrophies</a>,&nbsp;which are characterized by&nbsp;progressive loss of muscle bulk and symmetrical weakening of voluntary muscles. Symptoms of LGMD2C usually appear around 6-8 years of age, may be mild or severe, and can progress to loss of the ability to walk by 12-16 years. Symptoms may additionally include: enlargement (hypertrophy) of the calf muscle and tongue, diseases of the heart muscle (<a href=\"https://medlineplus.gov/cardiomyopathy.html\" target=\"_blank\">cardiomyopathy</a>), and respiratory abnormalities.[10986][11997] LGMD2C is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <a href=\"https://ghr.nlm.nih.gov/gene/SGCG\" target=\"_blank\"><em>SGCG</em></a> gene and is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal&nbsp;recessive</a> manner.[1117]&nbsp;Although there is no specific treatment or cure for LGMD2C, there are ways to manage the symptoms. A team of doctors or specialists is often needed to figure out the treatment options for each person.[10986]<br />\r\n<br />","dateModified":"2016-08-09T00:00:00","references":[{"referenceId":1117,"authors":"Victor A. McKusick","articleTitle":"Limb-girdle muscular dystrophy type 2C","bookWebsiteJournalTitle":"OMIM Database","date":"8/4/2016","volume":"","pages":"","url":"http://www.omim.org/entry/253700","authors2":"Cassandra L. Kniffin","placeOfPublication":"","publisher":""},{"referenceId":10986,"authors":"Glenn Lopate","articleTitle":"Limb-Girdle Muscular Dystrophy","bookWebsiteJournalTitle":"Medscape Reference","date":"October 28, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1170911-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11997,"authors":"Kate Bushby","articleTitle":"Limb-Girdle Muscular Dystrophies","bookWebsiteJournalTitle":"NORD","date":"2012","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/limb-girdle-muscular-dystrophies/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1833,"questionText":"How might limb-girdle muscular dystrophy, type 2C (LGMD2C) be treated?&nbsp;","answerText":"There is no specific treatment for LGMD2C. Management of the condition is based on each person's symptoms and may include:[1118]\r\n<ul>\r\n    <li>Weight control to avoid obesity\r\n    </li>\r\n    <li>Physical therapy and stretching exercises to promote mobility and prevent contractures\r\n    </li>\r\n    <li>Use of mechanical aids such as canes, walkers, orthotics, and wheelchairs as needed to help ambulation and mobility\r\n    </li>\r\n    <li>Monitoring and surgical intervention as needed for orthopedic complications such as foot deformity and <a href=\"http://www.niams.nih.gov/Health_Info/Scoliosis/scoliosis_ff.asp\" target=\"_blank\">scoliosis</a>\r\n    </li>\r\n    <li>Monitoring of respiratory function and use of respiratory aids when indicated\r\n    </li>\r\n    <li>Monitoring for evidence of diseases of the heart muscle (<a href=\"http://www.nlm.nih.gov/medlineplus/cardiomyopathy.html\" target=\"_blank\">cardiomyopathy</a>)</li>\r\n    <li>Social and emotional support and stimulation to maximize a sense of social involvement and productivity and to reduce the sense of social isolation common in these disorders</li>\r\n</ul>","dateModified":"2016-08-09T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":1118,"authors":"Pegoraro E and Hoffman EP","articleTitle":"Limb-Girdle Muscular Dystrophy Overview","bookWebsiteJournalTitle":"GeneReviews","date":"August 30, 2012","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1408/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3590,"phenoTypeName":"Abnormal macrophage morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13818,"phenoTypeName":"Broad-based gait","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3444,"phenoTypeName":"Calf muscle hypertrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5282,"phenoTypeName":"Calf muscle pseudohypertrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6235,"phenoTypeName":"Difficulty climbing stairs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4906,"phenoTypeName":"Difficulty running","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13576,"phenoTypeName":"EMG: myopathic abnormalities","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7771,"phenoTypeName":"EMG: myotonic discharges","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5299,"phenoTypeName":"EMG: myotonic runs","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2612,"phenoTypeName":"EMG: positive sharp waves","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11434,"phenoTypeName":"Frequent falls","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7736,"phenoTypeName":"Increased endomysial connective tissue","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6239,"phenoTypeName":"Increased variability in muscle fiber diameter","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4338,"phenoTypeName":"Lumbar hyperlordosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9753,"phenoTypeName":"Macroglossia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8994,"phenoTypeName":"Right ventricular hypertrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5270,"phenoTypeName":"Scapular winging","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13597,"phenoTypeName":"Upper limb muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14304,"phenoTypeName":"Waddling gait","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3901,"phenoTypeName":"Achilles tendon contracture","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5586,"phenoTypeName":"Gowers sign","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7795,"phenoTypeName":"Left ventricular systolic dysfunction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9870,"phenoTypeName":"Long face","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5294,"phenoTypeName":"Neck flexor weakness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13814,"phenoTypeName":"Scoliosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1178,"phenoTypeName":"Tip-toe gait","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","percentRanges":"-"},{"phenoTypeId":10993,"phenoTypeName":"Hyperlordosis","percentRanges":"-"},{"phenoTypeId":5289,"phenoTypeName":"Muscle fiber necrosis","percentRanges":"-"},{"phenoTypeId":6240,"phenoTypeName":"Muscular dystrophy","percentRanges":"-"},{"phenoTypeId":13723,"phenoTypeName":"Pneumonia","percentRanges":"-"},{"phenoTypeId":5257,"phenoTypeName":"Rapidly progressive","percentRanges":"-"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","percentRanges":"-"},{"phenoTypeId":13467,"phenoTypeName":"Right ventricular dilatation","percentRanges":"-"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Limb-girdle_muscular_dystrophy,_type_2C"}